MENU
TLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TriSalus Life Sciences (TLSI) Ownership - Who owns TriSalus Life Sciences?

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer... Show more

Profile

Industry
N/A
Address
6272 W. 91st Avenue
Phone
N/A
Employees
N/A
Web
https://trisaluslifesci.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
226.9M
P/E Ratio
0.08
Total Cash
13M
Projected Growth
N/A
Total Debt
33.12M
Revenue
32.14M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.26
Total Debt/Equity
N/A
Revenue/Share
1.25 USD as % of share price

Fundamentals

TLSI
Capitalization
227M
P/E Ratio
0.08
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
13M
Total Cash/Share
0.26
Total Debt
33.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.25%
Revenue
32.1M
ROE
N/A
Book Value
-34.37M
P/B Ratio
30.21
Cash Flow
N/A
Earnings
-1.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.14
Current Revenue Per Employee
83336.37
Dividends Per Share - Security
N/A
EBITDA
-22.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.69
Revenue To Assets
-130.34
Shares Held By Institutions
23M
Shares Outstanding - Current
49.9M
Total Liabilities
63M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-9.182
View a ticker or compare two or three
TLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
6272 W. 91st Avenue
Phone
N/A
Employees
N/A
Web
https://trisaluslifesci.com